吲哚菁绿荧光成像在困难腹腔镜肝切除中的回顾性队列研究
该回顾性队列研究纳入573例行腹腔镜肝切除的肝细胞癌患者,其中178例为高难度肝切除,比较ICG-FI与白光组的围手术期结局和生存。倾向评分匹配后,ICG-FI组转开腹率、引流管放置时间、严重并发症和术后住院时间均显著降低,无复发生存显著改善。
要点
- ICG-FI可降低困难腹腔镜肝切除的中转开腹率和严重并发症。
- ICG-FI组无复发生存显著优于白光组。
- ICG-FI对总生存的改善尚需前瞻性研究验证。
核心结论
- ICG-FI在困难腹腔镜肝切除中改善短期结局并提高无复发生存,但对总生存的影响需进一步验证。
研究设计与样本
- 回顾性队列研究分析2018年4月至2023年4月间573例行腹腔镜肝切除的患者,按ICG-FI或白光分组并行1:1倾向评分匹配。
主要发现
- 高难度肝切除178例中ICG-FI组47例、白光组131例,匹配后各39例。
- ICG-FI组中转开腹率2.6%对15.4%(P=0.048),严重并发症2.6%对15.4%(P=0.048)。
- ICG-FI组引流管放置时间7.0[5.0,8.0]天对7.0[6.0,9.5]天(P=0.048),术后住院7[4.5,9]天对8[7,10]天(P=0.045)。
- Kaplan-Meier分析显示ICG-FI组无复发生存显著优于白光组(P=0.021)。
- 无复发生存的独立预测因素包括ICG-FI、肝硬化和卫星结节。
关键数值与推荐
- 总生存的独立预测因素包括专家难度级别肝切除(HR=2.875,95%CI:1.331-6.207,P=0.007)和R0切除(HR=0.142,95%CI:0.028-0.734,P=0.020)。
临床怎么用
- 对困难腹腔镜肝切除的肝细胞癌患者,可考虑使用ICG-FI以降低中转开腹和严重并发症并改善无复发生存。
局限性
- 为单中心回顾性研究,ICG-FI对总生存的影响需大规模多中心前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indocyanine green fluorescence imaging (ICG-FI) is increasingly used in laparoscopic hepatectomy (LH). However, its efficacy in enhancing both short- and long-term outcomes in difficult LH for hepatocellular carcinoma (HCC) compared with traditional white light (WL) LH remains unclear. METHODS: This retrospective cohort study analyzed 573 patients who underwent LH between April 2018 and April 2023, stratified by the use of ICG-FI or WL. Propensity score matching (PSM, 1:1) was employed to minimize baseline discrepancies and reduce selection bias. Perioperative outcomes, overall survival (OS), and recurrence-free survival (RFS) were evaluated. Kaplan-Meier survival analysis was conducted to compare OS and RFS between groups, and Cox regression models were applied to identify independent prognostic factors. RESULTS: Among the 573 patients who underwent LH, 178 were classified as high-difficulty hepatectomies, including 47 patients in the ICG-FI group and 131 in the WL group. After PSM, 78 patients were matched, with 39 patients in each group. In both unmatched and matched cohorts, the ICG-FI group demonstrated significantly lower conversion rates (2.6% vs. 15.4%, P = 0.048), shorter durations of drainage tube placement (7.0 [5.0, 8.0] vs. 7.0 [6.0, 9.5], P = 0.048), fewer severe postoperative complications (2.6% vs. 15.4%, P = 0.048), and reduced postoperative hospital stays (7 [4.5, 9] vs. 8 [7, 10], P = 0.045). Kaplan-Meier analysis revealed significantly improved RFS in the ICG-FI group compared with the WL group (P = 0.021). Independent predictors of RFS included ICG-FI, liver cirrhosis, and the presence of satellite nodules. Independent predictors of OS included LH performed at the expert difficulty level (HR = 2.875, 95% CI: 1.331-6.207, P = 0.007) and R0 resection (HR = 0.142, 95% CI: 0.028-0.734, P = 0.020). CONCLUSIONS: ICG-FI demonstrates significant benefits in short-term outcomes and enhances RFS in patients undergoing difficult LH for HCC. However, its impact on OS warrants further validation through large-scale, multicenter prospective studies.
引用
- Mao T, Xie Q, Zhao X, et al. Indocyanine green fluorescence imaging (ICG-FI) in difficult laparoscopic hepatectomy for hepatocellular carcinoma: a retrospective propensity score-matched analysis. Surg Endosc. 2025. PMID: 40216627. doi:10.1007/s00464-025-11707-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。